BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26018687)

  • 1. 18F-FDG PET/CT of Liver Lymphoepithelioma-like Carcinoma.
    Lee SD; Chiu YL; Wu CS; Peng NJ
    Clin Nucl Med; 2015 Sep; 40(9):732-3. PubMed ID: 26018687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT, MRI, and 18F-FDG PET/CT in a patient with nested stromal epithelial tumor of the liver.
    Samarghandi A; Barker DW; Hingsbergen EA; Finegold MJ; Hall NC
    Clin Nucl Med; 2015 Feb; 40(2):131-3. PubMed ID: 25140542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET/CT in primary pulmonary lymphoepithelioma-like carcinoma.
    Dong A; Zhang J; Wang Y; Zhai Z; Zuo C
    Clin Nucl Med; 2015 Feb; 40(2):134-7. PubMed ID: 24300356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary.
    Yoon SN
    Clin Nucl Med; 2016 Nov; 41(11):e482-e484. PubMed ID: 27607167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma.
    Hu N; Tan Y; Luo J; Cheng Z; Wang Y
    Clin Nucl Med; 2016 Apr; 41(4):321-2. PubMed ID: 26914554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subdiaphragmatic gallstone mimicking hepatic malignancy on FDG PET/CT.
    Kim J; Siegel A; Yen SP; Seltzer M
    Clin Nucl Med; 2015 Apr; 40(4):347-8. PubMed ID: 25608158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of metastatic clear cell carcinoma of the Müllerian system originating from the peritoneum assessed by 18F-FDG PET/CT.
    Treglia G; Barizzi J; Paone G; Ceriani L; Bongiovanni M; Giovanella L
    Clin Nucl Med; 2015 Jan; 40(1):e58-60. PubMed ID: 24561679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic adenomatosis may mimic metastatic lesions of liver with 18F-FDG PET/CT.
    Sanli Y; Bakir B; Kuyumcu S; Ozkan ZG; Gulluoglu M; Bilge O; Turkmen C; Mudun A
    Clin Nucl Med; 2012 Jul; 37(7):697-8. PubMed ID: 22691518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solitary splenic metastasis from hepatocellular carcinoma detected on (18)F-FDG PET/CT.
    Kim DH; Jeong SY; Lee SW; Lee J; Ahn BC
    Clin Nucl Med; 2015 Jun; 40(6):e325-7. PubMed ID: 25546205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
    Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
    Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary anorectal melanoma on FDG PET/CT.
    Li ZG; Qin XJ
    Clin Nucl Med; 2014 Aug; 39(8):762-4. PubMed ID: 24978331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG PET/CT reveals the primary tumor in a patient with occult breast carcinoma undetected by other modalities.
    Liu M; Liu B; Song Y; Ding L; Dong L
    Clin Nucl Med; 2014 Aug; 39(8):755-7. PubMed ID: 24978343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging features of colorectal liver metastasis in FDG PET-CT: a retrospective correlative analysis between CT attenuation and FDG uptake.
    Au-Yeung AW; Luk WH; Lo AX
    Nucl Med Commun; 2012 Apr; 33(4):403-7. PubMed ID: 22273638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased 18F-FDG Uptake on PET/CT is Associated With Poor Arterial and Portal Perfusion on Multiphase CT.
    Hwang SH; Lee M; Lee N; Park S; Kim CK; Park MA; Yun M
    Clin Nucl Med; 2016 Apr; 41(4):296-301. PubMed ID: 26756099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT in gastric lymphoepithelioma-like carcinoma.
    Zhang Y; Li B; Hou J; Cai L; Shi H
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):202-4. PubMed ID: 26746813
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of [(18)F]-fluoroacetate PET/CT as a tumor-imaging modality: preclinical study in healthy volunteers and clinical evaluation in patients with liver tumor.
    Takemoto K; Hatano E; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Yamauchi H; Matsumura K; Zaima M; Toriguchi K; Tanabe K; Kitamura K; Seo S; Taura K; Endo K; Uemoto S; Higashi T
    Ann Nucl Med; 2014 May; 28(4):371-80. PubMed ID: 24599824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
    Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
    PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Oral Metastasis From Hepatocellular Carcinoma Displayed on 18F-FDG PET/CT Imaging.
    Jiang L; Gu T; Liu F; Luan L; Shi H
    Clin Nucl Med; 2016 Jan; 41(1):72-3. PubMed ID: 26359556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.